Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Kamada and Kedrion to develop immunoglobulin product for Covid-19

pharmaceutical-technologyApril 30, 2020

Tag: Kamada , Kedrion Biopharma , COVID-19 , Immunoglobulin

PharmaSources Customer Service